Gabather AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gabather AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8127
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidates in form of small molecules that integrate with the Gaba receptor complex in the brain. The company targets diseases include learning, cognition, sleep regulation, pain, anxiety, epilepsy, muscular tension and addiction, among others. It serves in the US, Canada, China and India. Gabather is headquartered in Malmo, Sweden.

Gabather AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gabather AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gabather AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 10
Gabather Enters into Research Agreement with UNSW 11
Equity Offering 12
Gabather Raises USD3.2 Million in Rights Offering of Units 12
Gabather to Raise up to USD4 Million in Rights Offering of Shares 13
Gabather Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14
Gabather Raises USD1 Million in Offering of Units 15
Gabather AB – Key Competitors 16
Gabather AB – Key Employees 17
Gabather AB – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Gabather AB, Pharmaceuticals & Healthcare, Key Facts 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Deals By Therapy Area, 2012 to YTD 2018 8
Gabather AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 10
Gabather Enters into Research Agreement with UNSW 11
Gabather Raises USD3.2 Million in Rights Offering of Units 12
Gabather to Raise up to USD4 Million in Rights Offering of Shares 13
Gabather Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14
Gabather Raises USD1 Million in Offering of Units 15
Gabather AB, Key Competitors 16
Gabather AB, Key Employees 17

List of Figures
Gabather AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Gabather AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BoneSupport AB:医療機器:M&Aディール及び事業提携情報
    Summary BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; infect …
  • NorthWestern Corporation:企業の戦略・SWOT・財務分析
    NorthWestern Corporation - Strategy, SWOT and Corporate Finance Report Summary NorthWestern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Health Care Service Corporation:企業の戦略・SWOT・財務分析
    Health Care Service Corporation - Strategy, SWOT and Corporate Finance Report Summary Health Care Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Omnicell Inc (OMCL)-医療機器分野:企業M&A・提携分析
    Summary Omnicell Inc (Omnicell) is a provider of automation and business analytics software solutions. It provides medication control and patient safety solutions to enhance operational efficiency and patient care in acute healthcare facilities. The company offers automation solutions such as medica …
  • Technip SA (TEC)-石油・ガス分野:企業M&A・提携分析
    Summary Technip SA (Technip) is a provider of project management, engineering and construction services to energy sector. It offers a comprehensive portfolio of technologies and services for the subsea oil and gas developments to the largest and most complex offshore and onshore infrastructures. The …
  • Snowy Hydro Ltd:企業の戦略的SWOT分析
    Snowy Hydro Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • RJK Explorations Ltd (RJX.A):企業の財務・戦略的SWOT分析
    Summary RJK Explorations Ltd (RJK) is a mineral exploration company. The company’s services include exploration, acquisition, and development of early stage mineral resource properties across Canada. It explores properties for gold, silver, and base metals with the resource properties located in Bri …
  • Sim Lian Group Ltd:企業の戦略・SWOT・財務情報
    Sim Lian Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Sim Lian Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • gategroup Holding AG:企業の戦略・SWOT・財務分析
    gategroup Holding AG - Strategy, SWOT and Corporate Finance Report Summary gategroup Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nutra Pharma Corp (NPHC):企業の財務・戦略的SWOT分析
    Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Alfa SAB de CV (ALFAA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa SAB de CV (Alfa) is a diversified company that operates in the petrochemical, refrigerated food, lightweight solutions, telecommunication, and oil and gas sectors. Alfa develops and manufactures high technology aluminum components for the power train and body structure of automotive. It …
  • Zeta Petroleum Plc (ZTA):企業の財務・戦略的SWOT分析
    Summary Zeta Petroleum Plc (Zeta) is an oil and gas exploration and production company. The company explores, develops and produces natural gas and crude oil. It owns and operates oil and gas assets such as Bobocu Gas Field, Suceava Concession, Jimbolia Oil Field, and Grivita Nord Oil Field. Zeta’s …
  • Xtant Medical Holdings Inc (XTNT):医療機器:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Continental Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Continental Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Continental Resources Inc (Continental Resources) is an oil and gas company involved in the distribution of fuel and related products and services. The company offerings include supply fulf …
  • Bukwang Pharm Co Ltd (003000):製薬・医療:M&Aディール及び事業提携情報
    Summary Bukwang Pharm Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s products portfolio includes dexid, thioctacid, levovir, legalon, Orfil, azeptin, lonasen, ixel, and asima, among others. Its pipeline products comprise …
  • Genentech Inc-医療機器分野:企業M&A・提携分析
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that develops and markets medicines to address serious medical needs. Its clinical development pipeline includes alectinib and Erlotinib for metastatic non-small cell lung cancer; Anti-ST2 for ast …
  • Liberty Global plc:企業のM&A・事業提携・投資動向
    Liberty Global plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Liberty Global plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Turbo Power Systems Ltd:企業の戦略的SWOT分析
    Turbo Power Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • John Keells Hotels Plc:企業の戦略・SWOT・財務分析
    John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆